Skip to main content
SpringerLink
Log in

Adnexal Disorders

  • Chapter
  • First Online:
Dermatoanthropology of Ethnic Skin and Hair

  • 1058 Accesses

Abstract

Pseudofolliculitis barbae (PB), acne keloidalis nuchae (AKN), dissecting cellulitis (DC), and hidradenitis suppurativa (HS) are chronic inflammatory disorders of hair-bearing areas that commonly affect individuals of African ancestry. They can be differentiated based on location (beard area versus scalp) and the presence of keloidal plaques, abscesses, and draining sinus tracts. HS is a disease that affects apocrine-gland bearing areas and predominately presents as comedones, nodules, abscesses, and draining sinus tracts in the axilla, groin, and buttocks. Although the underlying pathogenesis differs, the primary etiology of these conditions appears to involve occlusion and rupture of the hair follicle, resulting in an inflammatory response. Therapy is directed at preventing follicular occlusion, treating and preventing secondary infection, and interrupting the chronic inflammatory response that perpetuates these disorders. In extreme cases, surgery may be required. Understanding the epidemiology, pathogenesis, clinical presentation, and treatment of these conditions is essential for directing patient management and will be addressed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Winter H, Schissel D, Parry DAD, et al. An unusual A1a2Thr polymorphism in the 1A-Helical segment of the companion layer-specific keratin K6hf: evidence for a risk factor in the etiology of the common hair disorder pseudofolliculitis barbae. J Invest Dermatol. 2014;122(3):652–7.

    Article  Google Scholar 

  2. Alexander AM, Delph WI. Pseudofolliculitis barbae in the military. A medical, administrative and social problem. J Natl Med Assoc. 1974;66(6):459–79.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Edlich RF, Haines PC, Nichter LS, et al. Pseudofolliculitis barbae with keloids. J Emerg Med. 1986;4(4):283–6.

    Article  CAS  PubMed  Google Scholar 

  4. Perry PK, Cook-Bolden FE, Rahman Z, et al. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol. 2002;46(2):S113–9.

    Article  PubMed  Google Scholar 

  5. Alexis A, Heath CR, Halder RM. Folliculitis keloidalis nuchae and pseudofolliculitis barbae: are prevention and effective treatment within reach? Dermatol Clin. 2014;32(2):183–91. doi:10.1016/j.det.2013.12.001.

    Article  CAS  PubMed  Google Scholar 

  6. Craig GE. Shaving; its relationship to diseases of the bearded area of the face. AMA Arch Derm. 1955;71(1):11–3.

    Article  CAS  PubMed  Google Scholar 

  7. Halder RM. Pseudofolliculitis barbae and related disorders. Dermatol Clin. 1988;6(3):407–12.

    CAS  PubMed  Google Scholar 

  8. McLean WHI. 2004. Close shave for a keratin disorder-K6hf polymorphism linked to Pseudofolliculitis barbae. J Invest Dermatol. 2004;122(3): xi–xiii.

    Google Scholar 

  9. Garcia RL, White JW Jr. Pseudofolliculitis barbae in a woman. Arch Dermatol. 1978;114(12):1856.

    Google Scholar 

  10. Dilaimy M. Pseudofolliculitis of the legs. Arch Dermatol. 1976;112(4):507–8.

    Article  CAS  PubMed  Google Scholar 

  11. Smith JD, Odom RB. Pseudofolliculitis capitis. Arch Dermatol. 1977;113(3):328–9.

    Article  CAS  PubMed  Google Scholar 

  12. Bridgeman-Shah S. The medical and surgical therapy of pseudofolliculitis barbae. Dermatol Ther. 2004;17(2):158–63.

    Article  PubMed  Google Scholar 

  13. Cowley K, Vanoosthuyze K. Insights into shaving and its impact on skin. Br J Dermatol. 2012;166(Suppl 1):6–12. doi:10.1111/j.1365-2133.2011.10783.x.

    Article  PubMed  Google Scholar 

  14. Gray J, McMichael J. Pseudofolliculitis barbae: understanding the condition and the role of facial grooming. Int J Costemic Science. 2016;38(Suppl 1):24–7. doi:10.1111/ics.12331.

    Article  Google Scholar 

  15. Daniel A, Gustafson CJ, Zupkosky PJ, et al. Shave frequency and regimen variation effects on the management of pseudofolliculitis Barbae. J Drugs Dermatol. 2013;12(4):410–8.

    PubMed  Google Scholar 

  16. Kuchabal S, Kuchabal D. Shaving. Internet. J Dermatol. 2010;8(2):1–7.

    Google Scholar 

  17. Kligman AM, Mills OH Jr. Pseudofolliculitis of the beard and topically applied tretinoin. Arch Dermatol. 1973;107(4):551–2.

    Article  CAS  PubMed  Google Scholar 

  18. Weaver SM, Sagaral EC. Treatment of pseudofolliculitis barbae using the long-pulse Nd:YAG laser on skin types V and VI. Dermatol Surg. 2003;29(12):1187–91.

    PubMed  Google Scholar 

  19. Ross EV, Cooke LM, Oerstreet KA, et al. Treatment of pseudofolliculitis barbae in very dark skin with a long pulse Nd:YAG laser. J Natl Med Assoc. 2002;94(10):888–93.

    PubMed  PubMed Central  Google Scholar 

  20. Ross EV, Cooke LM, Timko AL, et al. Treatment of pseudofolliculitis barbae in skin types IV, V, and VI with a long-pulsed neodymium: yttrium aluminum garnet laser. J Am Acad Dermatol. 2002;47(2):263–70.

    Article  PubMed  Google Scholar 

  21. Greppi I. Diode laser hair removal of the black patient. Lasers Surg Med. 2001;28(2):150–5.

    Article  CAS  PubMed  Google Scholar 

  22. Smith EP, Winstanley D, Ross EV. Modified superlong pulse 810 nm diode laser in the treatment of pseudofolliculitis barbae in skin types V and VI. Dermatol Surg. 2005;31(3):297–301.

    Article  CAS  PubMed  Google Scholar 

  23. Schulze R, Meehan KJ, Lopez A, et al. Low-fluence 1,064-nm laser hair reduction for pseudofolliculitis barbae in skin types IV, V, and VI. Dermatol Surg. 2009;35(1):98–107. doi:10.1111/j.1524-4725.2008.34388.x.

    CAS  PubMed  Google Scholar 

  24. Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013;169(Suppl 3):91–7. doi:10.1111/bjd.12526.

    Article  PubMed  Google Scholar 

  25. Salami T, Omeife H, Samuel S. Prevalence of acne keloidalis nuchae in Nigerians. Int J Dermatol. 2007;46(5):482–4.

    Article  PubMed  Google Scholar 

  26. George AO, Akanji AO, Nduka EU, et al. Clinical biochemical and morphologic features of acne keloidalis in a black population. Int J Dermatol. 1993;32(10):714–6.

    Article  CAS  PubMed  Google Scholar 

  27. Ogunbiyi AO, Daramola OO, Alese OO. Prevalence of skin diseases in Ibadan. Nigeria. Int J Dermatol. 2004;43(1):31–6.

    Article  PubMed  Google Scholar 

  28. Child FJ, Fuller LC, Higgins EM, et al. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol. 1991;141(3):512–7.

    Article  Google Scholar 

  29. Khumalo NP, Jessop S, Gumedze F, et al. Hairdressing is associated with scalp disease in African schoolchildren. Br J Dermatol. 2007;157(1):106–10.

    Article  CAS  PubMed  Google Scholar 

  30. Khumalo NP, Jessop S, Gumedze F, et al. Hairdressing and the prevalence of scalp disease in African adults. Br J Dermatol. 2007;157(5):981–8.

    Article  CAS  PubMed  Google Scholar 

  31. Ogunbiyi A, George A. Acne keloidalis in females: case report and review of literature. J Natl Med Assoc. 2005;97(5):736–8.

    PubMed  PubMed Central  Google Scholar 

  32. Ogunbiyi A, Adedokun B. Perceived aetiological factors of folliculitis keloidalis nuchae (acne keloidalis) and treatment options among Nigerian men. Br J Dermatol. 2015;173(Suppl 2):22–5. doi:10.1111/bjd.13422.

    Article  CAS  PubMed  Google Scholar 

  33. Kelly AP. Pseudofolliculitis barbae and acne keloidalis nuchae. Dermatol Clin. 2003;21(4):645–53.

    Article  PubMed  Google Scholar 

  34. Khumalo NP, Gumedze F, Lehloenva R. Folliculitis keloidalis nuchae is associated with the risk for bleeding from haircuts. Int J Dermatol. 2011;50(10):1212–6. doi:10.1111/j.1365-4632.2010.04655.x.

    Article  PubMed  Google Scholar 

  35. Shapero J, Shapero H. Acne keloidalis nuchae is scar and keloid formation secondary to mechanically induced folliculitis. J Cutan Med Surg. 2011;15(4):238–40.

    Article  PubMed  Google Scholar 

  36. Sperling LC, Homoky C, Pratt L, et al. Acne keloidalis is a form of primary scarring alopecia. Arch Dermatol. 2000;136(4):479–84.

    Article  CAS  PubMed  Google Scholar 

  37. Goette DK, Berger TG. Acne keloidalis nuchae. A transepithelial elimination disorder. Int J Dermatol. 1987;26(7):442–4.

    Article  CAS  PubMed  Google Scholar 

  38. Burkhart CG, Burkhart C. Acne keloidalis is lichen simplex chronicus with fibrotic keloidal scarring. J Am Acad Dermatol. 1998;39:661.

    Article  CAS  PubMed  Google Scholar 

  39. Lee AH, Cho SY, Harris K, et al. Staphylococcus aureus and chronic folliculocentric pustuloses of the scalp—cause or association? Br J Dermatol. 2016;175(2):410–3.

    Article  CAS  PubMed  Google Scholar 

  40. Callender VD, Young CM, Haverstock CL, et al. An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. Cutis. 2005;75(6):317–21.

    PubMed  Google Scholar 

  41. Ramos-e-silva M, Pirmez R. Red face revisited: disorders of hair growth and the pilosebaceous unit. Clin Dermatol. 2014;32(6):784–99. doi:10.1016/j.clindermatol.2014.02.018.

    Article  PubMed  Google Scholar 

  42. Gloster HM Jr. The surgical management of extensive cases of acne keloidalis nuchae. Arch Dermatol. 2000;136(11):1376–9.

    Article  PubMed  Google Scholar 

  43. Glenn MJ, Bennett RG, Kelly AP. Acne keloidalis nuchae: treatment with excision and second-intention healing. J Am Acad Dermatol. 1995;33(2):243–6.

    Article  CAS  PubMed  Google Scholar 

  44. Kantor G, Ratz JL, Wheeland RG. Treatment of acne keloidalis nuchae with carbon dioxide laser. J Am Acad Dermatol. 1968;14(2):263–7.

    Article  Google Scholar 

  45. Hollander L. Treatment of folliculitis keloidalis chronica nuchae (acne keloid). AMA Arch Derm Syphilol. 1951;64(5):639–40.

    Article  CAS  PubMed  Google Scholar 

  46. Chicarilli ZN. Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp. Ann Plast Surg. 1987;18(3):230–7.

    Article  CAS  PubMed  Google Scholar 

  47. Rodney IJ, Onwudiwe OC, Callender VD, et al. Hair and scalp disorders in ethnic populations. J Drugs Dermatol. 2013;12(4):420–7.

    Google Scholar 

  48. Ross EK, Shapiro J. Management of hair loss. Dermatol Clin. 2005;23(2):227–43.

    Article  PubMed  Google Scholar 

  49. Benvenuto ME, Rebora A. Fluctuant nodules and alopecia of the scalp. Perifolliculitis capitis abscedens et suffodiens. 1992;128(8):1115–9.

    CAS  Google Scholar 

  50. Badaoui A, Reygagne P, Cavelier-Balloy B, et al. Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature. Br J Dermatol. 2016;174(2):421–3. doi:10.1111/bjd.13999.

    Article  CAS  PubMed  Google Scholar 

  51. Arneja JS, Vashi CN, Gursel E, et al. Management of fulminant dissecting cellulitis of the scalp in the pediatric population: Case report and literature review. Can J Plast Surg. 2007;15(4):211–4.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Koca R, Altinyazar HC, Ozen OI, et al. Dissecting cellulitis in a white male: response to isotretinoin. Int J Dermatol. 2002;41(8):509–13.

    Article  PubMed  Google Scholar 

  53. Madu P, Kundu RV. Follicular and scarring disorders in skin of color: presentation and management. Am J Clin Dermatol. 2014;15(4):307–21. doi:10.1007/s40257-014-0072-x.

    Article  PubMed  Google Scholar 

  54. Jacobs F, Metzler G, Kubiak J, et al. New approach in combined therapy of perifolliculitis capitis abscedens et suffodiens. Acta Derm Venereol. 2011;91(6):726–7. doi:10.2340/00015555-1146.

    Article  PubMed  Google Scholar 

  55. McMichael AJ. Hair and scalp disorders in ethnic populations. Dermatol Clin. 2003;21(4):629–44.

    Article  PubMed  Google Scholar 

  56. Curry SS, Gaither DH, King LE. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol. 1981;4(6):673–8.

    Article  CAS  PubMed  Google Scholar 

  57. Ramasastry SS, Granick MS, Boyd JB, et al. Severe perifolliculitis capitis with osteomyelitis. Ann Plast Surg. 1987;18(3):241–4.

    Article  CAS  PubMed  Google Scholar 

  58. Prasad SC, Bygum A. Successful treatment with alitretinoin of dissecting cellulitis of the scalp in keratitis-ichthyosis-deafness syndrome. Acta Derm Venereol. 2013;93(4):473–4. doi:10.2340/00015555-1499.

    Article  PubMed  Google Scholar 

  59. Scheinfeld N. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa. Dermatol Online J. 2014;20(5):22692.

    PubMed  Google Scholar 

  60. Thein M, Hogarth MB, Acland K. Seronegative arthritis associated with the follicular occlusion tetrad. Clin Exp Dermatol. 2004;29(5):550–2.

    Article  CAS  PubMed  Google Scholar 

  61. Ongchi DR, Fleming MG, Harris CA. Sternocleidomastoid hyperostosis: two cases with differing dermatologic syndromes. J Rheumatol. 1990;17(10):1415–8.

    CAS  PubMed  Google Scholar 

  62. Semble AL, McMichael AJ. Hair loss in patients with skin of color. Semin Cutan Med Surg. 2015;34(2):81–8. doi:10.12788/j.sder.2015.0145.

    Article  PubMed  Google Scholar 

  63. Greenblatt DT, Sheth N, Teixeira F. Dissecting cellulitis of the scalp responding to oral quinolones. Clin Exp Dermatol. 2008;33(1):99–100.

    CAS  PubMed  Google Scholar 

  64. Onderdijk AJ, Boer J. Successful treatment of dissecting cellulitis with ciprofloxacin. Clin Exp Dermatol. 2010;35(4):440. doi:10.1111/j.1365-2230.2009.03514.x.

    Article  CAS  PubMed  Google Scholar 

  65. Brook I. Recovery of anaerobic bacteria from a case of dissecting cellulitis. Int J Dermatol. 2006;45(2):168–9.

    Article  PubMed  Google Scholar 

  66. Goldsmith PC, Dowd PM. Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J R Soc Med. 1993;86(12):729–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobata with oral zinc. Br J Dermatol. 1999;141(6):1137–8.

    Article  CAS  PubMed  Google Scholar 

  68. Berne B, Venge P, Ohman S. Perifolliculitis capitis abscedens et suffodiens (Hoffman). Complete healing associated with oral zinc therapy. Arch Dermatol. 1985;121(8):1028–30.

    Article  CAS  PubMed  Google Scholar 

  69. Wollina U, Gemmeke A, Koch A. Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-alpha antagonist. J Clin Aesthet Dermato. 2012;5(4):36–9.

    Google Scholar 

  70. Navarini AA, Trüeb RM. 3 cases of dissecting cellulitis of the scalp treated with adalimumab: control of inflammation within residual structural disease. Arch Dermatol. 2010;146(5):517–20.

    Article  PubMed  Google Scholar 

  71. Taylor AE. Dissecting cellulitis of the scalp: response to isotretinoin. Lancet. 1987;2(8552):225.

    Article  CAS  PubMed  Google Scholar 

  72. Bjellerup M, Wallengren J. Familial perifolliculitis capitis abscedens et suffodiens in two brothers successfully treated with isotretinoin. J Am Acad Dermatol. 1990;23(4):752–3.

    Article  CAS  PubMed  Google Scholar 

  73. Khaled A, Zeglaoui F, Zoghlami A, et al. Dissecting cellulitis of the scalp: response to isotretinoin. J Eur Acad Dermatol Venereol. 2007;21(10):1430–1.

    Article  CAS  PubMed  Google Scholar 

  74. Scerri L, Williams HC, Allen BR. Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol. 1996;134(6):1105–8.

    Article  CAS  PubMed  Google Scholar 

  75. Boyd AS, Binhlam JQ. Use of an 800-nm pulsed-diode laser in the treatment of recalcitrant dissecting cellulitis of the scalp. Arch Dermatol. 2012;138(10):1291–3.

    Article  Google Scholar 

  76. Krasner BD, Hamzavi FH, Murakawa GJ. Dissecting cellulitis treated with the long-pulsed Nd:YAG laser. Dermatol Surg. 2006;32(8):1039–44.

    CAS  PubMed  Google Scholar 

  77. Chui CT, Berger TG, Price VH, et al. Recalcitrant scarring follicular disorders treated by laser-assisted hair removal: a preliminary report. Dermatol Surg. 1999;25(1):34–7.

    Article  CAS  PubMed  Google Scholar 

  78. Glass LF, Berman B, Laub D. Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser. J Dermatol Surg Oncol. 1989;159(6):673–6.

    Article  Google Scholar 

  79. Chinnaiyan P, Tena LB, Brenner MJ, et al. Modern external beam radiation therapy for refractory dissecting cellulitis of the scalp. Br J Dermatol. 2005;152(4):777–9.

    Article  CAS  PubMed  Google Scholar 

  80. Moschella SL, Klein MH, Miller RJ. Perifolliculitis capitis abscedens et suffodiens. Report of a successful therapeutic scalping. Arch Dermatol. 1967;96(2):195–7.

    Article  CAS  PubMed  Google Scholar 

  81. Williams CN, Cohen M, Ronan SG, et al. Dissecting cellulitis of the scalp. Plast Reconstr Surg. 1986;77(3):378–82.

    Article  CAS  PubMed  Google Scholar 

  82. Housewright CD, Rensvold E, Tidwell J, et al. Excisional surgery (scalpectomy) for dissecting cellulitis of the scalp. Dermatol Surg. 2011;37(8):1189–91. doi:10.1111/j.1524-4725.2011.02049.x.

    Article  CAS  PubMed  Google Scholar 

  83. Hintze JM, Howard BE, Donald CB, et al. Surgical management and reconstruction of Hoffman’s disease (dissecting cellulitis of the scalp). Case Rep Surg. 2016;2016:2123037. doi:10.1155/2016/2123037.

    PubMed  PubMed Central  Google Scholar 

  84. Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J. 2003;9(1):8.

    PubMed  Google Scholar 

  85. Adrian RM, Arndt KA. Perifolliculitis capitis: successful control with alternate-day corticosteroids. Ann Plast Surg. 1980;4(2):166–9.

    Article  CAS  PubMed  Google Scholar 

  86. Jemec GBE. Clinical practice. Hidradenitis suppurativa. New Engl J Med. 2012;366(2):158–64. doi:10.1056/NEJMcp1014163.

    Article  CAS  PubMed  Google Scholar 

  87. Pink AE, Simpson MA, Desai N, et al. γ-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis. J Invest Dermatol. 2013;133(3):601–7.

    Article  CAS  PubMed  Google Scholar 

  88. Onderdijk AJ, van der Zee HH, Esmann S, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473–478.

    Google Scholar 

  89. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539.

    Article  PubMed  Google Scholar 

  90. Vlassova N, Kuhn D, Okoye GA. Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis. Acta Derm Venereol. 2015;95(8):990–1.

    Article  CAS  PubMed  Google Scholar 

  91. Cosmatos I, Matcho A, Weinstein R. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68(3):412–9.

    Article  PubMed  Google Scholar 

  92. Reeder VJ, Mahan GM, Hamzavi IH. Ethnicity and hidradenitis suppurativa. J Invest Dermatol. 2014;134(11):2842–3.

    Article  CAS  PubMed  Google Scholar 

  93. Davis SA, Lin HC, Balrishnan R, et al. Hidradenitis Suppurativa management in the United States: An Analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases. Skin Appendage Disord. 2015;1(2):65–73.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. 1995;133(2):254–8.

    Article  CAS  PubMed  Google Scholar 

  95. Vazquez BG, Alikhan A, Weaver AL, et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013;133(1):97–103.

    Article  CAS  PubMed  Google Scholar 

  96. von Laffert M, Stadie V, Wohlrab J, et al. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011;164(2):367.

    Google Scholar 

  97. Danby FW, Jemec GB, Marsch WC, et al. Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. Br J Dermatol. 2013;168(5):1034.

    Google Scholar 

  98. van der Zee HH, Laman JD, Boer J, et al. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012;21(1):735–9.

    PubMed  Google Scholar 

  99. Ring HC, Riis Mikkelsen P, Miller IM, et al. The bacteriology of hidradenitis suppurativa: a systematic review. Exp Dermatol. 2015;24(10):727–31. doi:10.1111/exd.12793.

    Article  CAS  PubMed  Google Scholar 

  100. Hotz C, Boniotto M, Guguin A, et al. Intrinsic defect in keratinocyte function leads to inflammation in Hidradenitis suppurativa. J Invest Dermatol. 2016. doi:10.1016/j.jid.2016.04.036.

    PubMed  Google Scholar 

  101. van der Zee HH, de Ruiter L, van den Broecke DG, et al. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011;164:1292–8.

    Article  PubMed  CAS  Google Scholar 

  102. Schlapbach C, Hänni T, Yawalkar N, et al. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011;65:790–8.

    Article  CAS  PubMed  Google Scholar 

  103. Hunger RE, Surovy AM, Hassan AS, et al. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol. 2008;158:691–7.

    Article  CAS  PubMed  Google Scholar 

  104. van Rappard DC, Leenarts MF, Meijerink-van’t Oost L, et al. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa. J Dermatolog Treat. 2011;23(4):284–9. doi:10.3109/09546634.2011.571657.

  105. Gener G, Canoui-Poitrine F, Revuz JE, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219(2):148–54. doi:10.1159/000228334.

    Article  CAS  PubMed  Google Scholar 

  106. Join-Lambert O, Coignard H, Jais JP, et al. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology. 2011;222(1):49–58. doi:10.1159/000321716.

    Article  CAS  PubMed  Google Scholar 

  107. Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet. 1985;22:367–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Gao M, Wang PG, Cui Y, et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol. 2006;126(6):1302–6.

    Article  CAS  PubMed  Google Scholar 

  109. Wang B, Yang W, Wen W, et al. Gamma-secretase gene mutations in familial acne inversa. Science. 2010;330(6007):1065.

    Article  CAS  PubMed  Google Scholar 

  110. Li CR, Jiang MJ, Shen DB, et al. Two novel mutations of the nicastrin gene in Chinese patients with acne inversa. Br J Dermatol. 2011;165(2):415–418.

    Google Scholar 

  111. Liu Y, Gao M, Lv YM, et al. Confirmation by exome sequencing of the pathogenic role of NCSTN mutations in acne inversa (hidradenitis suppurativa). J Invest Dermatol. 2011;131(7):1570–2.

    Article  CAS  PubMed  Google Scholar 

  112. Pink AE, Simpson MA, Brice GW, et al. PSENEN and NCSTN mutations in familial hidradenitis suppurativa (acne inversa). J Invest Dermatol. 2011;131(7):1568–70.

    Article  CAS  PubMed  Google Scholar 

  113. Miskinyte S, Nassif A, Merabtene F, et al. Nicastrin mutations in French families with hidradenitis suppurativa. J Invest Dermatol. 2012;132:1728–30.

    Article  CAS  PubMed  Google Scholar 

  114. Zhang C, Wang L, Chen L, et al. Two novel mutations of the NCSTN gene in Chinese familial acne inverse. J Eur Acad Dermatol Venereol. 2012;27(12):1571–4.

    Article  PubMed  CAS  Google Scholar 

  115. Nomura Y, Nomura T, Sakai K, et al. A novel splice site mutation in NCSTN underlies a Japanese family with hidradenitis suppurativa. Br J Dermatol. 2012;68(1):206–9.

    Google Scholar 

  116. Chen S, Mattei P, You J, et al. γ-Secretase mutation in an African American family with hidradenitis Suppurativa. JAMA Dermatol. 2015;151(6):668–70.

    Article  PubMed  Google Scholar 

  117. Canoui-Poitrine F, Revuz JE, Wolkenstein P. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61(1):51–7. doi:10.1016/j.jaad.2009.02.013.

    Article  PubMed  Google Scholar 

  118. Thomas C, Rodby KA, Thomas J. Recalcitrant Hidradenitis Suppurativa: an investigation of demographics, surgical management, bacterial isolates, pharmacologic intervention, and patient-reported health outcomes. Am Surg. 2016;82(4):362–6.

    PubMed  Google Scholar 

  119. Losanoff JE, Sochaki P, Khoury N, Levi E, Salwen WA, Basson MD. Squamous cell carcinoma complicating chronic suppurative hydradenitis. Am Surg. 2011;77(11):1449–53.

    PubMed  Google Scholar 

  120. Rosen T. Squamous cell carcinoma: complication of chronic skin disorders in black patients. J Natl Med Assoc. 1986;78(12):1203–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  121. Roussomoustakaki M, Dimoulios P, Chatzicostas C, et al. Hidradenitis suppurativa associated with Crohn’s disease and spondyloarthropathy: response to anti-TNF therapy. J Gastroenterol. 2003;38(10):1000.

    Google Scholar 

  122. Marzano AV, Trevisan V, Gattorno M, et al. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013;149(6):762.

    Article  PubMed  Google Scholar 

  123. Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619–44. doi:10.1111/jdv.12966.

    Article  CAS  PubMed  Google Scholar 

  124. van der Zee HH, Jemec GB. New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes. J Am Acad Dermatol. 2015;73(Suppl 5):S23–6. doi:10.1016/j.jaad.2015.07.047.

    PubMed  Google Scholar 

  125. Micheletti RG (2015) An update on the diagnosis and treatment of hidradenitis suppurativa. Cutis. 2015;96(Suppl 6):7–12.

    Google Scholar 

  126. Simonart T. Hidradenitis suppurativa and smoking. J Am Acad Dermatol. 2010;62(1):149–50.

    Article  PubMed  Google Scholar 

  127. Sartorius K, Emtestam L, Jemec GB, et al. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco and obesity. Br J Dermatol. 2009;161(4):831.

    Article  CAS  PubMed  Google Scholar 

  128. Melnik BC, John SM, Schmitz G. Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndrome. Nutr Metab. 2011;8:41.

    Article  CAS  Google Scholar 

  129. Clemensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22(5):325.

    Article  Google Scholar 

  130. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39(6):971–4.

    Article  CAS  PubMed  Google Scholar 

  131. Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol. 2006;154(5):977–8.

    Article  PubMed  CAS  Google Scholar 

  132. Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35(1):36.

    Article  CAS  PubMed  Google Scholar 

  133. van der Zee HH, Boer J, Prens EP, et al. The effect of combined treatment with oral clindamycin and oral rifampin in patients with hidradenitis suppurativa. Dermatology. 2009;219(2):143–7.

    Article  PubMed  CAS  Google Scholar 

  134. Yazdanyar S, Boer J, Ingvarsson G, et al. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology. 2011;222(4):342–6.

    Article  CAS  PubMed  Google Scholar 

  135. Kaur MR, Lewis HM. Hidradenitis suppurativa treated with dapsone: a case series of five patients. J Dermatol Treat. 2006;17(4):211.

    Article  CAS  Google Scholar 

  136. Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40(1):73–6.

    Article  CAS  PubMed  Google Scholar 

  137. Mortimer PS, Dawber RP, Gales MA, et al. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115(3):263–8.

    Article  CAS  PubMed  Google Scholar 

  138. Farrell AM, Randall VA, Vafaee T, et al. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol. 1999;141(6):1138–9.

    Article  CAS  PubMed  Google Scholar 

  139. Joseph MA, Jayaseelan E, Ganapathi B, et al. Hidradenitis suppurativa treated with finasteride. J Dermatol Treat. 2005;16(1):75–8.

    Article  CAS  Google Scholar 

  140. Rose RF, Goodfield MJ, Clark SM. Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin. Clin Exp Dermatol. 2006;31(1):154–5.

    Article  CAS  PubMed  Google Scholar 

  141. Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med. 1995;88(5):289P–90P.

    CAS  PubMed  PubMed Central  Google Scholar 

  142. Soria A, Canoui-Poitrine F, Wolkenstein P. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients’ outcome assessment. Dermatology. 2009;218(2):134–5.

    Article  CAS  PubMed  Google Scholar 

  143. Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol. 2011;164(1):170.

    Article  CAS  PubMed  Google Scholar 

  144. Kraft JN, Searles GE. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg. 2007;11:125–31.

    Article  CAS  PubMed  Google Scholar 

  145. Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol Clin. 2010;28(4):779.

    Article  CAS  PubMed  Google Scholar 

  146. Grant A, Gonzalez T, Montgomery MO, et al. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62(2):205.

    Article  CAS  PubMed  Google Scholar 

  147. Lesage C, Adnot-Desanlis L, Perceau G, et al. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa. Eur J Dermatol. 2012;22(5):640–4.

    CAS  PubMed  Google Scholar 

  148. Delage M, Samimi M, Atlan M, et al. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers. Acta Derm Venereol. 2011;91(2):169–71.

    Article  PubMed  Google Scholar 

  149. Shuja F, Chan CS, Rosen T. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review. Dermatol Clin. 2010;28(3):511.

    Article  CAS  PubMed  Google Scholar 

  150. Kimball AB, Kerdel F, Adams D, et al. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157:846–55.

    Article  PubMed  Google Scholar 

  151. Lee RA, Dommasch E, Treat J, et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2009;60:565–73.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Adams DR, Yankura JA, Fogelberg AC, et al. Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol. 2010;146:501–4.

    CAS  PubMed  Google Scholar 

  153. Gulliver WP, Jemec GB, Baker KA. Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2012;26(7):911.

    Article  CAS  PubMed  Google Scholar 

  154. Blok JL, Li K, Brodmerkel C, et al. Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum. Br J Dermatol. 2016;174(4):839–46.

    Google Scholar 

  155. Leslie KS, Tripathi SV, Nguyen TV, et al. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. J Am Acad Dermatol. 2014;70:243–51.

    Article  CAS  PubMed  Google Scholar 

  156. Tzanetakou V, Kanni T, Giatrakou S, et al. Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial. JAMA Dermatol. 2016;152(1):52.

    Article  PubMed  Google Scholar 

  157. Ducroux E, Ocampo MA, Kanitakis J, et al. Hidradenitis suppurativa after renal transplantation: complete remission after switching from oral cyclosporine to oral tacrolimus. J Am Acad Dermatol. 2014;71(5):e210.

    Article  PubMed  Google Scholar 

  158. Mahmoud BH, Tierney E, Hexsel CL, et al. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol. 2010;62:637–45.

    Article  PubMed  Google Scholar 

  159. Tierney E, Mahmoud BH, Hexsel C, et al. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2009;35(8):1188–98. doi:10.1111/j.1524-4725.2009.01214.x.

    Article  CAS  PubMed  Google Scholar 

  160. Highton L, Chan WY, Khwaja N, et al. Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study. Plast Reconstr Surg. 2011;128(2):459–65.

    Article  CAS  PubMed  Google Scholar 

  161. Iwasaki J, Marra DE, Fincher EF, et al. Treatment of hidradenitis suppurativa with a nonablative radiofrequency device. Dermatol Surg. 2008;34(1):114–7.

    Article  CAS  PubMed  Google Scholar 

  162. Gold M, Bridges TM, Bradshaw VL, et al. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3(Suppl. 1):S32–5.

    PubMed  Google Scholar 

  163. Strauss RM, Pollock B, Stables GI, et al. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol. 2005;152(4):803.

    Google Scholar 

  164. Schweiger ES, Riddle CC, Aires DJ. Treatment of hidradenitis suppurativa by photodynamic therapy with aminolevulinic acid: preliminary results. J Drugs Dermatol 10(4):381–386.

    Google Scholar 

  165. Ellis LZ. Hidradenitis suppurativa: surgical and other management techniques. Dermatol Surg. 2012;38(4):517.

    Article  CAS  PubMed  Google Scholar 

  166. van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63:475–80.

    Article  PubMed  Google Scholar 

  167. Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36:208–13.

    Article  CAS  PubMed  Google Scholar 

  168. Menderes A, Sunay O, Vayvada H, et al. Surgical management of hidradenitis suppurativa. Int J Med Sci. 2010;7(4):240–47.

    Google Scholar 

  169. Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000;26:638–43.

    Article  CAS  PubMed  Google Scholar 

  170. Gillette. Advances in shaving technology: a review of the optimal shaving regimen for men highlighting technical advances associated with the fusion five-blade razor and its myth-bust- ing effect on pseudofolliculitis Barbae. Proctor & Gamble:1–24 http://www.pgdermatology.com/downloads/documents/Gillette_WhitePaper.pdf. Last accessed 30 May 2012.

  171. Kindred C, Oresajo CO, Yatskayer M, et al. Comparative evaluation of men’s depilatory composition versus razor in black men. Cutis. 2011;88(2):98–103.

    PubMed  Google Scholar 

  172. Cook-Bolden FE, Barba A, Halder R, et al. Twice-daily applications of benzoyl peroxide 5%/clindamycin 1% gel versus vehicle in the treatment of pseudofolliculitis barbae. Cutis. 2004;73(Suppl 6):18–24.

    PubMed  Google Scholar 

  173. Coley MK, Alexis AF. Dermatologic conditions in men of African ancestry. Expert Rev Dermatol. 2009;4:595–609.

    Article  Google Scholar 

  174. Xia Y, Cho S, Howard RS, et al. Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: a randomized, double-blinded, placebo-controlled trial. J Am Acad Dermatol. 2012;67(4):694–9.

    Article  CAS  PubMed  Google Scholar 

  175. Perricone NV. Treatment of pseudofolliculitis barbae with topical glycolic acid: a report of two studies. Cutis. 1993;52(4):232–5.

    CAS  PubMed  Google Scholar 

  176. Roberts WE. Chemical peeling in ethnic/dark skin. Dermatol Ther. 2004;17(2):196–205.

    Article  PubMed  Google Scholar 

  177. Diernaes JE, Bygum A. Successful treatment of recalcitrant folliculitis barbae and pseudofolliculitis barbae with photodynamic therapy. Photodiagnosis Photodyn Ther. 2013;10(4):651–3.

    Article  PubMed  Google Scholar 

  178. Barr J, Friedman A, Balwin H. Use of imiquimod and pimecrolimus cream in the treatment of acne keloidalis nuchae. J Am Acad Dermatol. 2005;52(suppl 3):P64.

    Google Scholar 

  179. Esmat SM, Abdel Hay RM, Abu Zeid OM, et al. The efficacy of laser-assisted hair removal in the treatment of acne keloidalis nuchae; a pilot study. Eur J Dermatol. 2012;22(5):645–50.

    PubMed  Google Scholar 

  180. Okoye GA, Rainer BM, Leung SG, et al. Improving acne keloidalis nuchae with targeted ultraviolet B treatment: a prospective, randomized, split-scalp comparison study. Br J Dermatol. 2014;171(5):1156–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  181. Bolz S, Jappe U, Hartschuh W. Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges. 2008;6(1):44–7.

    Article  PubMed  Google Scholar 

  182. Verdolini R, Clayton N, Smith A, et al. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. Eur Acad Dermatol Venereol. 2013;27(9):1101–8.

    Article  CAS  Google Scholar 

  183. Brocard A, Knol AC, Khammari A, et al. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214(4):325.

    Article  CAS  PubMed  Google Scholar 

  184. Dréno B, Khammari A, Brocard A, et al. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol. 2012;148(2):182–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Mount Sinai St. Luke’s and Mount Sinai West, 1090 Amsterdam Ave Ste 11B, New York, NY, 10025, USA

    Andrew F. Alexis & Bridget P. Kaufman

Authors
  1. Andrew F. Alexis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bridget P. Kaufman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew F. Alexis .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Center for Ethnic Skin, Boston University, Boston, Massachusetts, USA

    Neelam A. Vashi

  2. University of California, San Francisco, San Francisco, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Alexis, A.F., Kaufman, B.P. (2017). Adnexal Disorders. In: Vashi, N., Maibach, H. (eds) Dermatoanthropology of Ethnic Skin and Hair. Springer, Cham. https://doi.org/10.1007/978-3-319-53961-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53961-4_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53960-7

  • Online ISBN: 978-3-319-53961-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation